Literature DB >> 30253227

Long-term neurological outcomes in out-of-hospital cardiac arrest patients treated with targeted-temperature management.

Juan Caro-Codón1, Juan R Rey2, Esteban Lopez-de-Sa2, Óscar González Fernández2, Sandra O Rosillo2, Eduardo Armada2, Ángel M Iniesta2, Jaime Fernández de Bobadilla2, José Ruiz Cantador2, Laura Rodríguez Sotelo2, Francisco Javier Irazusta2, Verónica Rial Bastón2, Pablo Merás Colunga2, José Luis López-Sendón2.   

Abstract

BACKGROUND: This study aimed to assess long-term cognitive and functional outcomes in out-of-hospital cardiac arrest (OHCA) patients treated with targeted-temperature management, investigate the existence of prognostic factors that could be assessed during initial admission and evaluate the usefulness of classic neurological scales in this clinical scenario.
METHODS: Patients admitted due to OHCA from August 2007 to November 2015 and surviving at least one year were included. Each patient completed a structured interview focused on the collection of clinical, social and demographic data. All available information in clinical records was reviewed and a battery of neurocognitive and psychometric tests was performed.
RESULTS: Seventy-nine patients were finally included in the analysis. Forty-three patients (54.4%) scored below the usual cut-off points for the diagnosis of mild cognitive impairment, even though most of these deficits went unnoticed when patients were assessed using CPC and modified Rankin scale. Nineteen (24%) developed certain degree of impairment in their attention capacity and executive functions. A significant proportion developed new memory-related disorders (43%), depressive symptoms (17.7%), aggressive/uninhibited behavior (12.7%) and emotional lability (8.9%). A greater number of weekly hours of intellectual activity and a qualified job were independent protective factors for the development of cognitive impairment. However, being older at the time of the cardiac arrest was identified as a poor prognostic factor.
CONCLUSIONS: There is a high prevalence of long-term cognitive deficits and functional limitations in OHCA survivors. Most commonly used clinical scales in clinical practice are crude and lack sensitivity to detect most of these deficits.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Cognitive scales; Hypoxic ischemic brain injury; Long-term outcomes; Targeted-temperature management

Mesh:

Year:  2018        PMID: 30253227     DOI: 10.1016/j.resuscitation.2018.09.015

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  9 in total

1.  One-year outcomes in individual domains of the cerebral performance category extended.

Authors:  Katharyn L Flickinger; Stephany Jaramillo; Melissa J Repine; Allison C Koller; Margo Holm; Elizabeth Skidmore; Clif Callaway; Jon C Rittenberger
Journal:  Resusc Plus       Date:  2021-12-06

2.  Neuroprotection of NSC Therapy is Superior to Glibenclamide in Cardiac Arrest-Induced Brain Injury via Neuroinflammation Regulation.

Authors:  Zhuoran Wang; Shuai Zhang; Jian Du; Brittany Bolduc Lachance; Songyu Chen; Brian M Polster; Xiaofeng Jia
Journal:  Transl Stroke Res       Date:  2022-08-03       Impact factor: 6.800

Review 3.  Long Term Cognitive Function After Cardiac Arrest: A Mini-Review.

Authors:  Guri Hagberg; Håkon Ihle-Hansen; Else Charlotte Sandset; Dag Jacobsen; Henning Wimmer; Hege Ihle-Hansen
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

4.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.

Authors:  Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2021-03-25       Impact factor: 17.440

5.  Long-term physical and psychological outcomes after out-of-hospital cardiac arrest-protocol for a national cross-sectional survey of survivors and their relatives (the DANCAS survey).

Authors:  Vicky L Joshi; Lars H Tang; Britt Borregaard; Line Zinckernagel; Tina Broby Mikkelsen; Rod S Taylor; Sofie Raahauge Christiansen; Jørgen Feldbæk Nielsen; Ann Dorthe Zwisler
Journal:  BMJ Open       Date:  2021-04-02       Impact factor: 2.692

Review 6.  [Ethics of resuscitation and end of life decisions].

Authors:  Spyros D Mentzelopoulos; Keith Couper; Patrick Van de Voorde; Patrick Druwé; Marieke Blom; Gavin D Perkins; Ileana Lulic; Jana Djakow; Violetta Raffay; Gisela Lilja; Leo Bossaert
Journal:  Notf Rett Med       Date:  2021-06-02       Impact factor: 0.826

7.  Dataset regarding baseline and follow-up characteristics of out-of-hospital cardiac arrest patients focused on neurological outcomes.

Authors:  Juan Caro-Codón; Juan R Rey; Esteban Lopez-de-Sa; Óscar González Fernández; Sandra O Rosillo; Eduardo Armada; Ángel M Iniesta; Jaime Fernández de Bobadilla; José Ruiz Cantador; Laura Rodríguez Sotelo; Francisco Javier Irazusta; Verónica Rial Bastón; Pablo Merás Colunga; José Luis López-Sendón
Journal:  Data Brief       Date:  2018-10-27

8.  Geographical Differences and the National Meeting Effect in Patients with Out-of-Hospital Cardiac Arrests: A JCS-ReSS Study Report.

Authors:  Tetsuya Yumoto; Hiromichi Naito; Takashi Yorifuji; Yoshio Tahara; Naohiro Yonemoto; Hiroshi Nonogi; Ken Nagao; Takanori Ikeda; Naoki Sato; Hiroyuki Tsutsui
Journal:  Int J Environ Res Public Health       Date:  2019-12-16       Impact factor: 3.390

9.  Dose optimization of early high-dose valproic acid for neuroprotection in a swine cardiac arrest model.

Authors:  Cindy H Hsu; Mohamad H Tiba; Brendan M McCracken; Carmen I Colmenero; Zachary Pickell; Danielle C Leander; Anne M Weitzel; Sarita Raghunayakula; Jinhui Liao; Tulasi Jinka; Brandon C Cummings; Manjunath P Pai; Hasan B Alam; Kevin R Ward; Thomas H Sanderson; Robert W Neumar
Journal:  Resusc Plus       Date:  2020-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.